Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Chronic use of 1 mg/day finasteride for hair loss may delay prostate cancer diagnosis by lowering PSA levels.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

DHT deficiency increases iNOS expression in rat testis and epididymis.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

AT-Grow, a natural product, might help with a common type of hair loss by reducing DHT levels.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Androgens, male hormones, play a role in both men and women's health, and testosterone therapy can help women with low levels, but it's not suitable for pregnant or lactating women, or those with certain conditions.

Men might have a version of the female disease, polycystic ovarian syndrome, shown by changes in hormone levels and early baldness, but more research is needed to fully understand it.

Women with a certain type of hair loss have more copper in the back of their head than the front, and treatment can normalize hair but not copper levels.

Oral testosterone therapy raises heart risk more than other methods.

Photobiomodulation helps protect hair follicle cells from damage caused by DHT.

Male pattern baldness is mainly caused by brain heat stress, not DHT.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Most men seeking hair transplants have Male Pattern Baldness, influenced by genetics, age, and testosterone, while women's hair loss can be affected by thyroid function, iron, testosterone, prolactin, ferritin levels, and certain conditions. Follicular Unit Extraction is a popular hair transplant technique.

A new gene, JMJD1C, may affect testosterone levels in men.

Men with isolated hypogonadotropic hypogonadism have partial steroid deficiencies, while those with panhypopituitarism have severe deficiencies.

Finasteride helps prevent hair loss and promote hair growth.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Epilation and DHT cause skin calcification by increasing ATP and calcium deposits.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

Creatine does not cause hair loss.